Dr. Ortiz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Novartis Pharmaceuticals Corporation
1 Health Plaza
East Hanover, NJ 07936
Summary
- Benjamin Ortiz, MD is a pediatric specialist located in East Hanover, NJ with experience in asthma, food allergy, pediatrics, clinical research, and qualitative research. After graduating from the Icahn School of Medicine at Mount Sinai in 1998, he completed his Residency there, before going on to hold a variety of roles - academic pediatrics roles at Columbia University Medical Center and Harlem Hospital Center, Medical Officer at US FDA, Medical Director at Novartis Pharmaceuticals, Sanofi US and Regeneron. He is currently a Senior Clinical Development Medical Director in the Immunology Drug Development division. His noteworthy contributions to medical literature have been recognized and cited by other publications multiple times. Among his accolades are Leveraging Collaboration Award from the FDA in 2012 and the Partnerships Make a Difference Award from Columbia University Medical Center-Mailman School of Public Health in 2007.
Education & Training
- Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 1998 - 2001
- Icahn School of Medicine at Mount SinaiClass of 1998
- Columbia UniversityB.A., Biochemistry, 1988 - 1992
Certifications & Licensure
- CT State Medical License 2012 - 2018
- NY State Medical License 1999 - 2016
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Leveraging Collaboration Award US Food and Drug Administration, 2012
- Leadership Fellows Program National Hispanic Medical Association, 2010
- Partnerships Make a Difference Award Columbia University Medical Center-Mailman School of Public Health, 2007
- Join now to see all
Clinical Trials
- Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy Start of enrollment: 2021 Dec 07
- Long-term Extension Study of Ligelizumab in Food Allergy Start of enrollment: 2023 Apr 27
Publications & Presentations
PubMed
- 3 citationsDupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline.Arnaud Bourdin, J Christian Virchow, Alberto Papi, Njira L Lugogo, Philip Bardin
Respiratory Medicine. 2022-10-01 - 12 citationsImpact of baseline patient characteristics on dupilumab efficacy in type 2 asthma.William W. Busse, Pierluigi Paggiaro, Xavier Muñoz, Thomas B. Casale, Mario Castro
The European Respiratory Journal. 2021-10-01 - 36 citationsEfficacy and safety of dupilumab in patients with uncontrolled severe CRSwNP and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phas...Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert, Leda Mannent, G. Walter Canonica
Allergy. 2021-08-30
Journal Articles
- PerspectiveOrtiz B, Infectious Diseases in Children, 6/1/2012
- A Community-based Strategy for Improving Asthma Management and Outcomes for PreschoolersFindley SE, Thomas G, Madera-Reese R, McLeod N, Kintala S, Andres Martinez R, Ortiz B and Hermann E, Journal of Urban Health, 2/1/2011
- Childhood Asthma and Extreme Values of Body Mass Index: The Harlem Children's Zone Asthma InitiativeKwon HL, Ortiz B, Shoemaker K, Jean-Louis B, Northridge ME, Vaughan RD, Swaner R, Marx T, Goodman A, Borrell LN, Nicholas SW; for the Harlem Children's Zone Asthma Ini..., Journal of Urban Health, 5/1/2006
- Join now to see all
Books/Book Chapters
Lectures
- Impact of Omalizumab on All-Cause and Asthma-Related Healthcare Resource Utilization in Patients With Moderate or Severe Persistent AsthmaAmsterdam, The Netherlands - 11/1/2014
- Impact of Omalizumab on Poor Asthma Control Events and Medication Utilization in Patients With Moderate or Severe Persistent AsthmaAmsterdam, The Netherlands - 11/1/2014
- The Harlem Children's Zone Asthma Initiative: From Home to School to Hospital. A Model of Community-Based Participatory ResearchHartford, CT - 1/1/2012
- Join now to see all
Other
- What Matters to Communities? Using Community-Based Participatory Research to Ask and Answer Questions Regarding the Environment and HealthNorthridge ME, Shoemaker K, Jean-Louis B, Ortiz B, Swaner R, Vaughan RD, Cushman LF, Hutchinson VE, and Nicholas SW, Environmental Health Perspectives, Essays on the Future of Environmental Health Research: A Tribute
3/1/2005 - Improving childhood asthma through community-based service delivery: The Harlem Children's Zone Asthma InitiativeNicholas SW, Hutchinson VE, Ortiz B, Klihr-Beall S, Jean-Louis B, Shoemaker K, Singleton C, Credell J, Swaner R, Vaughan RD, Northridge ME, Cushman LF, Polley E, Golem..., Morbidity and Mortality Weekly Report, United States Centers for Disease Control and Prevention
1/1/2005
Press Mentions
- How to Treat Diarrhea in Infants and Young ChildrenOctober 31st, 2011
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: